CClinicalTrials.gg
CompletedNCT07449767RT-DIA-OLDERUpdated Sep 30, 2026

Effects of Resistance-Based Multicomponent Training Incorporating Respiratory Exercise on Diaphragm Thickness, Hepatic Attenuation, and Quality of Life in Healthy Older Men: A Randomized Controlled Trial

An interventional study of Resistance Training Group (RT) and Control in Older Men, Quality of Life and Fatty Liver, sponsored by Gümüşhane Universıty. Completed at 1 site in Turkey (Türkiye). Open to male participants aged 60 Years to 75 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-30.

Sponsored by Gümüşhane Universıty · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
60 Years to 75 Years
Sex
Male
01

Study summary

This randomized controlled trial investigated the effects of a four-week moderate-intensity resistance training program on diaphragm thickness, hepatic fat density, and health-related quality of life in healthy community-dwelling older men aged 60-75 years. Thirty participants were randomly assigned to a resistance training group or control group. Diaphragm thickness and hepatic attenuation were assessed using non-contrast computed tomography, and quality of life was evaluated using the SF-12 questionnaire. The primary outcome was change in diaphragm thickness. Secondary exploratory outcomes included hepatic fat density and SF-12 physical and mental health scores.

Read the detailed description

Aging is associated with progressive decline in respiratory muscle morphology, metabolic health, and perceived quality of life. While resistance training is well established for peripheral muscle adaptation, its short-term effects on diaphragm morphology and hepatic tissue density remain insufficiently investigated.

This randomized controlled pre-test-post-test trial enrolled 30 healthy men aged 60-75 years. Participants were randomly allocated (1:1) to:

Resistance Training Group (RT) Control Group (CON) The RT group completed a supervised moderate-intensity resistance training program three times per week for four weeks (30-40 minutes/session, RPE 12-15). The control group maintained usual daily activities.

Primary Outcome:

Change in diaphragm thickness (mm) assessed by non-contrast CT

Secondary Outcomes (Exploratory):

Hepatic attenuation (Hounsfield Units) via CT SF-12 Physical Health Score SF-12 Mental Health Score The study was approved by the Hitit University Scientific Research Ethics Committee (2025/0464) and conducted according to the Declaration of Helsinki.

02

Conditions studied

  • Older Men
  • Quality of Life
  • Fatty Liver
  • Resistance Training
  • Aging

Browse trials for

Keywords

  • Older men
  • Quality of life
  • Fatty liver
  • Diaphragm thickness
  • Resistance training
  • Aging
03

In context

Fatty Liver

1,451 studies on the registry are indexed under Fatty Liver; 292 are open to participants now.

This study's enrollment of 30 is below the median of 60 across 1,003 interventional studies indexed under Fatty Liver.

Browse Fatty Liver studies →

Lead sponsor

Gümüşhane Universıty is the lead sponsor of 34 studies on the registry; 5 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
60 Years to 75 Years
Sexes eligible
Male
Accepts healthy volunteers
Yes

Inclusion criteria

  • Male
  • Age 60-75 years
  • Community-dwelling and functionally independent
  • No structured exercise program in past 6 months
  • No musculoskeletal injury in past 6 months
  • Ability to provide written informed consent
  • Stable neuropsychological status

Exclusion criteria

Exclusion Criteria:

  • Chronic liver disease
  • Uncontrolled cardiovascular or pulmonary disease
  • Recent respiratory infection
  • Use of medications affecting muscle or liver metabolism (e.g., systemic corticosteroids, anabolic agents, hepatotoxic drugs)
  • Participation in structured exercise or respiratory training within past 6 months
  • Unstable thyroid hormone replacement therapy
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
30 participants (actual)

Study arms

  • Experimental
    Resistance Training Group (RT)

    Participants performed supervised resistance training three times per week for four weeks. Each session lasted 30-40 minutes and included: Lower body exercises (sit-to-stand, step-ups, glute bridge) Upper body exercises (wall push-ups, resistance band row, biceps curl) Core exercises Breathing exercises (diaphragmatic breathing, pursed-lip breathing) Warm-up protocol (10 minutes dynamic mobility) Intensity: Borg RPE 12-15 Rest interval: 60 seconds between sets

    Behavioral: Resistance Training Group (RT) · Other: Control

  • No intervention
    CONTROL

    Participants maintained their usual daily routines without structured exercise intervention.

Interventions

  • BehavioralResistance Training Group (RT)

    Structured Moderate-Intensity Resistance Training

  • OtherControl

    Participants maintained their usual daily routines without structured exercise intervention.

06

What researchers measure

Primary outcomes

  1. Diaphragm Thickness

    Diaphragm thickness measured in millimeters using non-contrast computed tomography at full inspiration.

    Time frame: 4 weeks

Secondary outcomes

  1. Hepatic Fat Density

    Measurement: CT attenuation (Hounsfield Units) Single ROI in segment VIII

    Time frame: 4 weeks

  2. SF-12 Physical Health Score

    Instrument: Short Form-12 Health Survey The physical and mental health scores of the SF-12 subdimensions range from 0 to 100, with higher scores representing better health.

    Time frame: 4 weeks

  3. SF-12 Mental Health Score

    Instrument: Short Form-12 Health Survey The physical and mental health scores of the SF-12 subdimensions range from 0 to 100, with higher scores representing better health.

    Time frame: 4 weeks

  4. Six-minute walk test (6MWT)

    Functional exercise capacity was assessed using the 6-Minute Walk Test (6MWT) according to a standardised protocol based on established 6MWT recommendations. The test was performed on a flat, straight 30-m indoor corridor, with the course clearly marked at both ends. Participants were instructed to walk back and forth along the corridor for 6 min at a self-selected walking pace, with the objective of covering the greatest possible distance within the allotted time.

    Time frame: 4 WEEK

07

Study locations

1 site
  • Gumushane Univetsity
    Gümüşhane, Trabzon, Ordu, Giresun, Rize, Artvin, Gümüşhane 29600, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No — Individual participant data will not be shared due to the absence of prior consent for data sharing and the potential risk of re-identification in a small, single-center sample. Only aggregate results will be disseminated.

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Minor edits
Nothing that changes what the study is or who can join. Edited: secondary outcomes
1 update, last Sep 30, 2026
Show all 1 update
  1. Sep 30, 2026
    Minor edits only
    + 1 other change: secondary outcomes

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07449767
Lead sponsor
Gümüşhane Universıty
Responsible party
Coşkun YILMAZ (ASSOC. PROF., Gümüşhane Universıty) — Principal investigator
First posted
Mar 4, 2026
Start date
Mar 10, 2026
Primary completion
Apr 25, 2026
Completion
May 30, 2026
Last update
Sep 30, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion